Skip to main content
Clinical Trials/NCT02685722
NCT02685722CompletedPhase 1

Umbilical Cord Mesenchymal Stem Cells Between Gel Treatment Difficult Skin Ulcer Healing Efficacy and Safety of Random, Open, Before-and-after Study

Chinese PLA General Hospital1 site in 1 country20 target enrollmentStarted: January 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Frequency of Adverse Events

Study Overview

Brief Summary

This study for a six-month trials, Randomized, open, and parallel comparison before and after its own, Stage test includes screening stage, treatment period and follow-up period. In accordance with chronic wound criteria for the patient, By producing the principle of random number, Were randomly divided into UC-MSCs Gel group or Gel group, The researchers according to the situation of wound healing time and decided to use the secondary treatment, To observe the clinical efficacy and safety.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
17 Years to 78 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Older than 17 year old male or female (pregnancy);
  • •Has the ability to care for, has the ability to self signed informed consent, 7 to 17 years of age must be signed by the guardian informed consent;
  • •The process of psychological stability, can finish the tes

Exclusion Criteria

  • •Allergic constitution, or known allergic to pork or beef source products, gao min physique person;
  • •The wound is more than 10 cm by 10 cm;
  • •People with mental illness, drug abusers and or other items;
  • •1 month used or are using the sugar metabolism of drugs, such as corticosteroids, thiazide diuretics, tricyclic antidepressants, etc;
  • •3 month participated in other similar test;
  • •Serious infectious disease not controller;
  • •With surgery, such as severe trauma stress situation;
  • •Always had a history of tumor;
  • •Clinical researchers or for other reasons can't cooperate with the doctors, and other information is not suitable for clinical study of patients.

Arms & Interventions

UC-MSCs Gel group

Experimental

This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.treatment period and follow-up period.In accordance with chronic wound criteria for the patient,By producing the principle of random number,Were randomly divided into UC-MSCs Gel group or Gel group,The researchers according to the situation of wound healing time and decided to use the secondary treatment,to observe the clinical efficacy and safety.

Intervention: UC-MSCs Gel group (Biological)

Gel group

Experimental

This study for a six-month trials,Randomized, open, and parallel comparison before and after its own,Stage test includes screening stage, stochastic screening of more than a month difficult to heal wounds 20 people.treatment period and follow-up period.In accordance with chronic wound criteria for the patient,By producing the principle of random number,Were randomly divided into UC-MSCs Gel group or Gel group,The researchers according to the situation of wound healing time and decided to use the secondary treatment,to observe the clinical efficacy and safety.

Intervention: Gel group (Other)

Outcomes

Primary Outcomes

Frequency of Adverse Events

Time Frame: 6 months

Frequency and severity of Adverse Events

Secondary Outcomes

  • Relative Wound Area Regression of 40% or More at 6 Week(6 week)

Investigators

Sponsor
Chinese PLA General Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiaobing Fu

Principal Investigator

Chinese PLA General Hospital

Study Sites (1)

Loading locations...

Similar Trials